<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br />                            WRN <span id='am-634' about='obo:IMR_0010034' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001 obo:IMR_0000207'><span id='am-635' property="oboInOwl:hasDbXref" content="GO:0004386" datatype="xsd:string"></span><span id='am-636' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-637' property="oboInOwl:id" content="IMR:0010034" datatype="xsd:string"></span><span id='am-638' property="rdfs:label" content="helicase" datatype="xsd:string"></span>helicase</span> promotes repair DNA double-strand breaks <br />                            caused aberrant mismatch repair chromium-DNA adducts <br />   <br />                            Abstract <br />                                  Recent studies yeast processing DNA-double strand breaks (DSB)                                  recombination repair involves Sgs1 helicase. Human cells Sgs1 homologues                                  unknown selectivity significance repair different DSB types. examined NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  importance WRN helicase repair <span id='am-54' about='obo:IMR_0700368' typeof='owl:Thing'><span id='am-55' property="rdfs:label" content="MLRS_RAT" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="MLC-2" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasExactSynonym" content="DTNB" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="Mylpf" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="myosin light chain, phosphorylatable, fast skeletal muscle" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasExactSynonym" content="G2" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasExactSynonym" content="myosin light chain, phosphorylatable, fast skeletal muscle" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasDbXref" content="UniProt:P04466" datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="Fast skeletal myosin light chain 2" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasExactSynonym" content="Mylpf" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="G2" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasExactSynonym" content="MLC-2" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:id" content="IMR:0700368" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasExactSynonym" content="Myosin regulatory light chain 2, skeletal muscle isoform" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-70' property="rdfs:label" content="Myosin regulatory light chain 2, skeletal muscle isoform" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasExactSynonym" content="Fast skeletal myosin light chain 2" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="DTNB" datatype="xsd:string"></span>G2</span>-specific DSB caused abnormal mismatch repair <br />                                  (MMR) ternary Cr-DNA adducts. Cr(VI) induced rapid dispersal WRN                                  nucleolus resulting prolonged retention nucleoplasm. loss MSH2 MLH1 <br />                                  MMR proteins abolished long-term initial WRN relocalization. WRN-deficient <br />                                  fibroblasts hypersensitive Cr(VI)-induced clonogenic death contained high levels                                  persistent DSB detected  947;-H2AX/53BP1 foci pulsed-field gel electrophoresis. WRN                                  involved recombination repair Cr-induced DNA damage, evidenced WRN-RAD51 <br />                                  colocalization defective formation RAD51 foci absence WRN. accumulation <br />                                  unrepaired DSB WRN-depleted cells rescued inactivation MMR, indicating <br />                                  MMR-generated DSB key substrate WRN action Cr(VI)-treated cells. <br />                                  Competition limited amounts WRN primary cells G2 processes telomere <br />                                  rebuilding recombinational repair expected increase persistence Cr-induced DSB                                  cause telomeric abnormalities tissues chronically chromate-exposed workers. work <br />                                  provides demonstration major importance WRN repair specific class                                  DSB human cells. <br />  <br />  <br />                            Introduction <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Werner syndrome (<span id='am-645' about='obo:IMR_0701302' typeof='owl:Thing'><span id='am-646' property="rdfs:label" content="FLJ38671" datatype="xsd:string"></span><span id='am-647' property="rdfs:label" content="elastin" datatype="xsd:string"></span><span id='am-648' property="rdfs:label" content="ELN" datatype="xsd:string"></span><span id='am-649' property="rdfs:label" content="SVAS" datatype="xsd:string"></span><span id='am-650' property="oboInOwl:hasExactSynonym" content="ELN" datatype="xsd:string"></span><span id='am-651' property="oboInOwl:hasDbXref" content="UniProt:P15502" datatype="xsd:string"></span><span id='am-652' property="rdfs:label" content="WS" datatype="xsd:string"></span><span id='am-653' property="rdfs:label" content="ELN_HUMAN" datatype="xsd:string"></span><span id='am-654' property="oboInOwl:hasExactSynonym" content="Tropoelastin" datatype="xsd:string"></span><span id='am-655' property="oboInOwl:hasExactSynonym" content="SVAS" datatype="xsd:string"></span><span id='am-656' property="oboInOwl:hasExactSynonym" content="FLJ43523" datatype="xsd:string"></span><span id='am-657' property="oboInOwl:id" content="IMR:0701302" datatype="xsd:string"></span><span id='am-658' property="oboInOwl:hasExactSynonym" content="FLJ38671" datatype="xsd:string"></span><span id='am-659' property="rdfs:label" content="FLJ43523" datatype="xsd:string"></span><span id='am-660' property="oboInOwl:hasExactSynonym" content="elastin" datatype="xsd:string"></span><span id='am-661' property="oboInOwl:hasExactSynonym" content="WBS" datatype="xsd:string"></span><span id='am-662' property="rdfs:label" content="Elastin" datatype="xsd:string"></span><span id='am-663' property="rdfs:label" content="WBS" datatype="xsd:string"></span><span id='am-664' property="oboInOwl:hasExactSynonym" content="WS" datatype="xsd:string"></span><span id='am-665' property="oboInOwl:hasExactSynonym" content="Elastin" datatype="xsd:string"></span><span id='am-666' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-667' property="rdfs:label" content="Tropoelastin" datatype="xsd:string"></span>WS</span>) rare genetic disorder premature ageing manifested                                             early appearance gray hair, cataracts, scleroderma, diabetes increased incidence                                             cancer.1 8211;3 WRN, <span id='am-498' about='obo:IMR_0000949' typeof='owl:Thing obo:IMR_0000001'><span id='am-499' property="oboInOwl:id" content="IMR:0000949" datatype="xsd:string"></span><span id='am-500' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-501' property="rdfs:label" content="protein" datatype="xsd:string"></span>protein</span> mutated Werner syndrome, unique  <br />                                             member human RecQ helicase family contains helicase exonuclease <br />                                             activities.1,3 Normal localization WRN nucleolar4 8211;6 afflicted individuals,                                             protein missing nuclear localization signal resulting exclusion                                             nucleus.1,2 WS cells display prolonged S-phase,7 low proliferative capacity3 increased <br />                                             sensitivity drugs S-phase dependent toxicity.8 8211;10 preferred substrates WRN <br />                                             action include various types 3- 4-way DNA junctions, bubbles, extrahelical loops                                             DNA overhangs.3,11,12 abnormal DNA structures arise spontaneously areas <br />                                             DNA repeats induced incomplete repair replication. WRN                                             capable resolving broad range alternative DNA structures ability                                             recognize structures process unwinding cleavage reactions.1 8211;3 <br />  <br />  <br />                                             WRN interacts proteins involved repair DNA double-strand breaks <br />                                             (DSB)13 8211;18 localizes sites laser-induced DSB live cells.19  WS <br />                                             cells exhibited mild sensitivity ionizing radiation clonogenic survival <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             experiments,2,16 indicative minor role WRN overall DSB <br />                                             repair. Recent studies yeast RecQ helicase Sgs1 stimulated <br />                                             recombination repair DSB essential function redundant DNA <br />                                             ends resection pathways.20,21 RecQ helicase BLM appears play role analogous                                             Sgs1 campthothecin-treated human cells acts parallel EXO1                                             promote recombination-associated foci cell survival.22 presence RecQ <br />                                             members human cells potentially indicates individual helicases participate                                             repair different classes DSB. currently unknown repair specific DSB                                             human cells particularly dependent WRN involves helicase. <br />  <br />                                             work, investigated importance WRN cellular survival repair DSB <br />                                             induced potent human carcinogen chromium(VI). main source DSB Cr(VI)- <br />                                             treated human cells misprocessing Cr-DNA damage mismatch repair (MMR).23 8211;25 <br />                                             majority Cr-induced DSB formed G2 phase following replication Cr- <br />                                             adducted DNA.23,24 Ternary Cr-DNA adducts, cysteine-Cr-DNA ascorbate-Cr- <br />                                             DNA crosslinks, particularly good substrates recognition MMR proteins.24,25 <br />                                             adducts primary cause mutagenic responses generated shuttle- <br />                                             vector plasmids damaged Cr(VI) reduction vitro ascorbate26,27 cysteine.28 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Chronic formation toxic DSB MMR activity repetitive exposures Cr(VI)                                             proposed promote selection transformation-prone, Cr-resistant cells lacking <br />                                             MMR, providing explanation unusually high frequency microsatellite <br />                                             instability (marker inactive MMR) lung cancers chromate workers.29 Unlike <br />                                             agents MMR-dependent mechanisms cytotoxicity,30 8211;32 formation DSB <br />                                             Cr-exposed cells unusually rapid results unprecedented activation                                             MSH6 MSH3 branches MMR.25 MSH3 specifically recognizes repairs <br />                                             mismatches containing insertion/deletion loops,33,34 pointing potential formation                                             structures Cr-damaged DNA. Extrahelical loops high affinity substrates                                             WRN helicase1 8211;3 interfere activity DNA helicases.  <br />                                             possible repair MMR-generated DSB Cr-damaged DNA engage WRN. <br />                                             Cr-induced DSB suited testing involvement WRN homologous <br />                                             recombination principal DSB repair process S/G2 cells main target <br />                                             activity RecQ helicases lower organisms.20,21 <br />  <br />                               Materials Methods <br />                               Cell cultures drug treatments <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Human SV40 transformed fibroblast lines GM00637H (NF cells) GM00847 (LNS cells) <br />                                             purchased Coriell Cell Repository. SV40 immortalized Werner syndrome <br />                                             fibroblasts AG11395 (WS cells) obtained NIA Aging Cell Culture Repository. <br />                                             Primary human lung IMR90 fibroblasts colon HCT116 (MLH1 8722;/ 8722;) cells purchased <br />                                             American Type Culture Collection. HCT116+ch3 (MLH1+) cell line gift <br />                                             T. Kunkel. NF, WS IMR90 fibroblasts cultured DMEM supplemented <br />                                             penicillin-streptomycin serum (15% NF WS, 10% IMR90). LNS cells <br />                                             grown MEM 10% serum. HCT116 cells grown DMEM-F12 medium <br />                                             containing 10% serum penicillin-streptomycin. Media HCT116+ch3 cells <br />                                             additionally included 600  956;g/ml geneticin. cell lines grown 37 176;C humidified <br />                                             atmosphere containing 95% air-5% CO2. Cells exposed K2CrO4 [Cr(VI)] 3 hr                                             serum-free medium. increase cellular ascorbate concentrations, cells incubated                                             90 min 1 mM dehydroascorbic acid Krebs-HEPES buffer supplemented 0.5 <br />                                             mM glucose.35 Cellular ascorbate measured modified HPLC procedure based  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 3 <br />  <br />  <br />                                             fluorescent detection specific conjugate 1,2-diamino-4,5-dimethoxybenzene <br />                                             dihydrochloride.36 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Clonogenic survival <br />                                             total 2000 cells seeded 100-mm dishes day prior treatments                                             Cr(VI). dishes used dose. 14 days exposure, colonies                                             fixed 100% methanol stained Giemsa solution counted. Clonogenic <br />                                             experiments repeated twice. <br />  <br />                               Western blotting <br />                                             Cells collected scraping, washed twice cold phosphate-buffered saline (PBS) <br />                                             resuspended buffer containing 50 mM Tris pH 8.0, 250 mM NaCl, 1% NP40, 0.1% <br />                                             <span id='am-426' about='obo:IMR_0200659' typeof='owl:Thing'><span id='am-427' property="rdfs:label" content="serine dehydratase" datatype="xsd:string"></span><span id='am-428' property="oboInOwl:hasExactSynonym" content="EC 4.3.1.19" datatype="xsd:string"></span><span id='am-429' property="rdfs:label" content="L-serine deaminase" datatype="xsd:string"></span><span id='am-430' property="oboInOwl:hasExactSynonym" content="L-threonine dehydratase" datatype="xsd:string"></span><span id='am-431' property="rdfs:label" content="L-threonine dehydratase" datatype="xsd:string"></span><span id='am-432' property="oboInOwl:hasExactSynonym" content="EC 4.3.1.17" datatype="xsd:string"></span><span id='am-433' property="oboInOwl:id" content="IMR:0200659" datatype="xsd:string"></span><span id='am-434' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-435' property="oboInOwl:hasExactSynonym" content="L-serine deaminase" datatype="xsd:string"></span><span id='am-436' property="oboInOwl:hasExactSynonym" content="serine dehydratase" datatype="xsd:string"></span><span id='am-437' property="rdfs:label" content="SDH" datatype="xsd:string"></span><span id='am-438' property="rdfs:label" content="SDS" datatype="xsd:string"></span><span id='am-439' property="oboInOwl:hasExactSynonym" content="SDH" datatype="xsd:string"></span><span id='am-440' property="rdfs:label" content="SDHL_HUMAN" datatype="xsd:string"></span><span id='am-441' property="rdfs:label" content="EC 4.3.1.17" datatype="xsd:string"></span><span id='am-442' property="rdfs:label" content="TDH" datatype="xsd:string"></span><span id='am-443' property="oboInOwl:hasExactSynonym" content="L-serine dehydratase/L-threonine deaminase" datatype="xsd:string"></span><span id='am-444' property="oboInOwl:hasExactSynonym" content="SDS" datatype="xsd:string"></span><span id='am-445' property="rdfs:label" content="L-serine dehydratase/L-threonine deaminase" datatype="xsd:string"></span><span id='am-446' property="oboInOwl:hasExactSynonym" content="TDH" datatype="xsd:string"></span><span id='am-447' property="rdfs:label" content="EC 4.3.1.19" datatype="xsd:string"></span><span id='am-448' property="oboInOwl:hasDbXref" content="UniProt:P20132" datatype="xsd:string"></span>SDS</span>, 5 mM EDTA, 2 mM Na3VO4, 10 mM Na2P2O7, 10 mM <span id='am-81' about='obo:IMR_0701377' typeof='owl:Thing'><span id='am-82' property="rdfs:label" content="IL8/NAP1 form IV" datatype="xsd:string"></span><span id='am-83' property="rdfs:label" content="(Ser-IL-8)72" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasExactSynonym" content="IL-8(8-77)" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasExactSynonym" content="SMALL INDUCIBLE CYTOKINE SUBFAMILY B, MEMBER 8" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasExactSynonym" content="IL8" datatype="xsd:string"></span><span id='am-87' property="oboInOwl:hasExactSynonym" content="IL-8(6-77)" datatype="xsd:string"></span><span id='am-88' property="rdfs:label" content="NAP1" datatype="xsd:string"></span><span id='am-89' property="rdfs:label" content="IL-8(9-77)" datatype="xsd:string"></span><span id='am-90' property="rdfs:label" content="GCP/IL-8 protein II" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasExactSynonym" content="CXCL8" datatype="xsd:string"></span><span id='am-92' property="rdfs:label" content="MDNCF-b" datatype="xsd:string"></span><span id='am-93' property="rdfs:label" content="IL-8(6-77)" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasExactSynonym" content="NAP1" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein III" datatype="xsd:string"></span><span id='am-96' property="rdfs:label" content="interleukin 8" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasExactSynonym" content="NEUTROPHIL-ACTIVATING PEPTIDE 1" datatype="xsd:string"></span><span id='am-98' property="rdfs:label" content="b-ENAP" datatype="xsd:string"></span><span id='am-99' property="rdfs:label" content="IL8" datatype="xsd:string"></span><span id='am-100' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein VI" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasExactSynonym" content="SCYB8" datatype="xsd:string"></span><span id='am-102' property="rdfs:label" content="GCP/IL-8 protein I" datatype="xsd:string"></span><span id='am-103' property="rdfs:label" content="LYNAP" datatype="xsd:string"></span><span id='am-104' property="rdfs:label" content="Neutrophil-activating factor" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:hasExactSynonym" content="MONAP" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasExactSynonym" content="IL-8(5-77)" datatype="xsd:string"></span><span id='am-107' property="rdfs:label" content="CHEMOKINE, CXC MOTIF, LIGAND 8" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form IV" datatype="xsd:string"></span><span id='am-109' property="oboInOwl:hasExactSynonym" content="MDNCF" datatype="xsd:string"></span><span id='am-110' property="rdfs:label" content="Protein 3-10C" datatype="xsd:string"></span><span id='am-111' property="rdfs:label" content="GCP/IL-8 protein IV" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasExactSynonym" content="(Ser-IL-8)72" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasExactSynonym" content="GCP1" datatype="xsd:string"></span><span id='am-114' property="rdfs:label" content="Monocyte-derived neutrophil chemotactic factor" datatype="xsd:string"></span><span id='am-115' property="rdfs:label" content="MDNCF-a" datatype="xsd:string"></span><span id='am-116' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein II" datatype="xsd:string"></span><span id='am-117' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein V" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasExactSynonym" content="MDNCF-b" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:hasExactSynonym" content="Interleukin-8" datatype="xsd:string"></span><span id='am-120' property="oboInOwl:hasExactSynonym" content="NAF" datatype="xsd:string"></span><span id='am-121' property="oboInOwl:hasExactSynonym" content="C-X-C motif chemokine 8" datatype="xsd:string"></span><span id='am-122' property="rdfs:label" content="IL8/NAP1 form V" datatype="xsd:string"></span><span id='am-123' property="rdfs:label" content="TSG-1" datatype="xsd:string"></span><span id='am-124' property="rdfs:label" content="GCP1" datatype="xsd:string"></span><span id='am-125' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form II" datatype="xsd:string"></span><span id='am-126' property="rdfs:label" content="LUCT" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasExactSynonym" content="IL-8(1-77)" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-129' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form I" datatype="xsd:string"></span><span id='am-130' property="oboInOwl:hasExactSynonym" content="MDNCF-a" datatype="xsd:string"></span><span id='am-131' property="rdfs:label" content="Emoctakin" datatype="xsd:string"></span><span id='am-132' property="rdfs:label" content="Monocyte-derived neutrophil-activating peptide" datatype="xsd:string"></span><span id='am-133' property="rdfs:label" content="SCYB8" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:hasExactSynonym" content="NAP-1" datatype="xsd:string"></span><span id='am-135' property="oboInOwl:hasExactSynonym" content="Granulocyte chemotactic protein 1" datatype="xsd:string"></span><span id='am-136' property="oboInOwl:hasExactSynonym" content="CHEMOKINE, CXC MOTIF, LIGAND 8" datatype="xsd:string"></span><span id='am-137' property="rdfs:label" content="IL-8(1-77)" datatype="xsd:string"></span><span id='am-138' property="oboInOwl:id" content="IMR:0701377" datatype="xsd:string"></span><span id='am-139' property="oboInOwl:hasExactSynonym" content="AMCF-I" datatype="xsd:string"></span><span id='am-140' property="rdfs:label" content="IL8/NAP1 form VI" datatype="xsd:string"></span><span id='am-141' property="rdfs:label" content="Lymphocyte-derived neutrophil-activating factor" datatype="xsd:string"></span><span id='am-142' property="rdfs:label" content="IL8/NAP1 form I" datatype="xsd:string"></span><span id='am-143' property="oboInOwl:hasExactSynonym" content="LECT" datatype="xsd:string"></span><span id='am-144' property="oboInOwl:hasExactSynonym" content="T-cell chemotactic factor" datatype="xsd:string"></span><span id='am-145' property="oboInOwl:hasExactSynonym" content="Monocyte-derived neutrophil-activating peptide" datatype="xsd:string"></span><span id='am-146' property="oboInOwl:hasExactSynonym" content="Emoctakin" datatype="xsd:string"></span><span id='am-147' property="oboInOwl:hasExactSynonym" content="IL-8(7-77)" datatype="xsd:string"></span><span id='am-148' property="oboInOwl:hasExactSynonym" content="GCP-1" datatype="xsd:string"></span><span id='am-149' property="rdfs:label" content="T-cell chemotactic factor" datatype="xsd:string"></span><span id='am-150' property="rdfs:label" content="MONAP" datatype="xsd:string"></span><span id='am-151' property="oboInOwl:hasExactSynonym" content="interleukin 8" datatype="xsd:string"></span><span id='am-152' property="rdfs:label" content="IL-8(5-77)" datatype="xsd:string"></span><span id='am-153' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein IV" datatype="xsd:string"></span><span id='am-154' property="rdfs:label" content="(Ala-IL-8)77" datatype="xsd:string"></span><span id='am-155' property="rdfs:label" content="IL-8" datatype="xsd:string"></span><span id='am-156' property="oboInOwl:hasExactSynonym" content="LYNAP" datatype="xsd:string"></span><span id='am-157' property="oboInOwl:hasDbXref" content="UniProt:P10145" datatype="xsd:string"></span><span id='am-158' property="rdfs:label" content="IL-8(8-77)" datatype="xsd:string"></span><span id='am-159' property="rdfs:label" content="GCP/IL-8 protein V" datatype="xsd:string"></span><span id='am-160' property="oboInOwl:hasExactSynonym" content="(Ala-IL-8)77" datatype="xsd:string"></span><span id='am-161' property="rdfs:label" content="K60" datatype="xsd:string"></span><span id='am-162' property="rdfs:label" content="SMALL INDUCIBLE CYTOKINE SUBFAMILY B, MEMBER 8" datatype="xsd:string"></span><span id='am-163' property="oboInOwl:hasExactSynonym" content="GCP/IL-8 protein I" datatype="xsd:string"></span><span id='am-164' property="oboInOwl:hasExactSynonym" content="IL-8" datatype="xsd:string"></span><span id='am-165' property="rdfs:label" content="Neutrophil-activating protein 1" datatype="xsd:string"></span><span id='am-166' property="oboInOwl:hasExactSynonym" content="Protein 3-10C" datatype="xsd:string"></span><span id='am-167' property="rdfs:label" content="NAF" datatype="xsd:string"></span><span id='am-168' property="rdfs:label" content="Interleukin-8" datatype="xsd:string"></span><span id='am-169' property="rdfs:label" content="LECT" datatype="xsd:string"></span><span id='am-170' property="oboInOwl:hasExactSynonym" content="LUCT" datatype="xsd:string"></span><span id='am-171' property="oboInOwl:hasExactSynonym" content="MDNCF-c" datatype="xsd:string"></span><span id='am-172' property="rdfs:label" content="Granulocyte chemotactic protein 1" datatype="xsd:string"></span><span id='am-173' property="oboInOwl:hasExactSynonym" content="Neutrophil-activating factor" datatype="xsd:string"></span><span id='am-174' property="rdfs:label" content="NAP-1" datatype="xsd:string"></span><span id='am-175' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form III" datatype="xsd:string"></span><span id='am-176' property="oboInOwl:hasExactSynonym" content="Monocyte-derived neutrophil chemotactic factor" datatype="xsd:string"></span><span id='am-177' property="rdfs:label" content="MDNCF" datatype="xsd:string"></span><span id='am-178' property="oboInOwl:hasExactSynonym" content="3-10C" datatype="xsd:string"></span><span id='am-179' property="rdfs:label" content="IL-8(7-77)" datatype="xsd:string"></span><span id='am-180' property="rdfs:label" content="MDNCF-c" datatype="xsd:string"></span><span id='am-181' property="oboInOwl:hasExactSynonym" content="K60" datatype="xsd:string"></span><span id='am-182' property="rdfs:label" content="IL8/NAP1 form II" datatype="xsd:string"></span><span id='am-183' property="rdfs:label" content="AMCF-I" datatype="xsd:string"></span><span id='am-184' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form V" datatype="xsd:string"></span><span id='am-185' property="rdfs:label" content="IL8/NAP1 form III" datatype="xsd:string"></span><span id='am-186' property="rdfs:label" content="C-X-C motif chemokine 8" datatype="xsd:string"></span><span id='am-187' property="oboInOwl:hasExactSynonym" content="IL-8(9-77)" datatype="xsd:string"></span><span id='am-188' property="rdfs:label" content="GCP-1" datatype="xsd:string"></span><span id='am-189' property="rdfs:label" content="IL8_HUMAN" datatype="xsd:string"></span><span id='am-190' property="rdfs:label" content="GCP/IL-8 protein VI" datatype="xsd:string"></span><span id='am-191' property="rdfs:label" content="3-10C" datatype="xsd:string"></span><span id='am-192' property="rdfs:label" content="NEUTROPHIL-ACTIVATING PEPTIDE 1" datatype="xsd:string"></span><span id='am-193' property="rdfs:label" content="GCP/IL-8 protein III" datatype="xsd:string"></span><span id='am-194' property="oboInOwl:hasExactSynonym" content="Lymphocyte-derived neutrophil-activating factor" datatype="xsd:string"></span><span id='am-195' property="oboInOwl:hasExactSynonym" content="Neutrophil-activating protein 1" datatype="xsd:string"></span><span id='am-196' property="oboInOwl:hasExactSynonym" content="IL8/NAP1 form VI" datatype="xsd:string"></span><span id='am-197' property="oboInOwl:hasExactSynonym" content="b-ENAP" datatype="xsd:string"></span><span id='am-198' property="rdfs:label" content="CXCL8" datatype="xsd:string"></span><span id='am-199' property="oboInOwl:hasExactSynonym" content="TSG-1" datatype="xsd:string"></span>NaF</span>, 1 mM PMSF                                             <span id='am-73' about='obo:IMR_0000304' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0010044 obo:IMR_0000001 obo:IMR_0000207'><span id='am-74' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="GO:0008233" datatype="xsd:string"></span><span id='am-76' property="rdfs:label" content="protease" datatype="xsd:string"></span><span id='am-77' property="rdfs:label" content="peptidase" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:id" content="IMR:0000304" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasExactSynonym" content="peptidase" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasDbXref" content="EC:3.4.-.-" datatype="xsd:string"></span>protease</span> inhibitor cocktail. Lysates incubated <span id='am-391' about='obo:IMR_0703988' typeof='owl:Thing'><span id='am-392' property="oboInOwl:hasExactSynonym" content="Casp1" datatype="xsd:string"></span><span id='am-393' property="rdfs:label" content="Interleukin-1 beta convertase" datatype="xsd:string"></span><span id='am-394' property="rdfs:label" content="p45" datatype="xsd:string"></span><span id='am-395' property="oboInOwl:hasExactSynonym" content="EC 3.4.22.36" datatype="xsd:string"></span><span id='am-396' property="rdfs:label" content="Il1bc" datatype="xsd:string"></span><span id='am-397' property="rdfs:label" content="Caspase-1 subunit p20" datatype="xsd:string"></span><span id='am-398' property="rdfs:label" content="Interleukin-1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-399' property="rdfs:label" content="interleukin 1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-400' property="oboInOwl:hasDbXref" content="UniProt:P29452" datatype="xsd:string"></span><span id='am-401' property="oboInOwl:hasExactSynonym" content="Caspase-1 subunit p10" datatype="xsd:string"></span><span id='am-402' property="oboInOwl:hasExactSynonym" content="CASP-1" datatype="xsd:string"></span><span id='am-403' property="rdfs:label" content="CASP1_MOUSE" datatype="xsd:string"></span><span id='am-404' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-405' property="oboInOwl:id" content="IMR:0703988" datatype="xsd:string"></span><span id='am-406' property="oboInOwl:hasExactSynonym" content="interleukin 1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-407' property="rdfs:label" content="IL-1BC" datatype="xsd:string"></span><span id='am-408' property="oboInOwl:hasExactSynonym" content="Caspase-1 subunit p20" datatype="xsd:string"></span><span id='am-409' property="oboInOwl:hasExactSynonym" content="IL-1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-410' property="oboInOwl:hasExactSynonym" content="caspase 1" datatype="xsd:string"></span><span id='am-411' property="oboInOwl:hasExactSynonym" content="ICE" datatype="xsd:string"></span><span id='am-412' property="rdfs:label" content="caspase 1" datatype="xsd:string"></span><span id='am-413' property="oboInOwl:hasExactSynonym" content="Interleukin-1 beta convertase" datatype="xsd:string"></span><span id='am-414' property="rdfs:label" content="CASP-1" datatype="xsd:string"></span><span id='am-415' property="rdfs:label" content="Caspase-1" datatype="xsd:string"></span><span id='am-416' property="rdfs:label" content="IL-1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-417' property="oboInOwl:hasExactSynonym" content="Interleukin-1 beta-converting enzyme" datatype="xsd:string"></span><span id='am-418' property="oboInOwl:hasExactSynonym" content="p45" datatype="xsd:string"></span><span id='am-419' property="rdfs:label" content="EC 3.4.22.36" datatype="xsd:string"></span><span id='am-420' property="rdfs:label" content="Casp1" datatype="xsd:string"></span><span id='am-421' property="oboInOwl:hasExactSynonym" content="Caspase-1" datatype="xsd:string"></span><span id='am-422' property="rdfs:label" content="ICE" datatype="xsd:string"></span><span id='am-423' property="oboInOwl:hasExactSynonym" content="Il1bc" datatype="xsd:string"></span><span id='am-424' property="rdfs:label" content="Caspase-1 subunit p10" datatype="xsd:string"></span><span id='am-425' property="oboInOwl:hasExactSynonym" content="IL-1BC" datatype="xsd:string"></span>ice</span> 10 min cell debris <br />                                             spun speed 10,000  215; g 5 min 4 176;C. Samples denatured 2X <br />                                             loading buffer 10% 2-mercaptoethanol boiled 10 min. Proteins separated <br />                                             SDS-polyacrylamide gel electrophoresis electrotransferred ImmunoBlot PVDF <br />                                             membrane (Bio-Rad). Primary antibodies rabbit polyclonal anti-WRN (Santa Cruz <br />                                             Biotechnology), mouse anti-MLH1, anti-MSH6 anti-MSH2 (BD Biosciences). Protein <br />                                             bands visualized using horseradish <span id='am-639' about='obo:IMR_0010052' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001 obo:IMR_0000207 obo:IMR_0000952'><span id='am-640' property="oboInOwl:id" content="IMR:0010052" datatype="xsd:string"></span><span id='am-641' property="oboInOwl:hasDbXref" content="EC:1.11.-.-" datatype="xsd:string"></span><span id='am-642' property="oboInOwl:hasDbXref" content="GO:0004601" datatype="xsd:string"></span><span id='am-643' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-644' property="rdfs:label" content="peroxidase" datatype="xsd:string"></span>peroxidase</span>-conjugated secondary antibodies <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             (Upstate) enhanced chemiluminescence <span id='am-225' about='obo:IMR_0000074' typeof='owl:Thing obo:IMR_0000210 obo:IMR_0000054 obo:IMR_0000063 obo:IMR_0000949 obo:IMR_0000512 obo:IMR_0000209 obo:IMR_0010050 obo:IMR_0000001 obo:IMR_0000207 obo:IMR_0001012'><span id='am-226' property="rdfs:label" content="Kit" datatype="xsd:string"></span><span id='am-227' property="oboInOwl:hasExactSynonym" content="mast/stem cell growth factor receptor" datatype="xsd:string"></span><span id='am-228' property="rdfs:label" content="c-Kit" datatype="xsd:string"></span><span id='am-229' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-230' property="oboInOwl:hasExactSynonym" content="c-Kit" datatype="xsd:string"></span><span id='am-231' property="oboInOwl:id" content="IMR:0000074" datatype="xsd:string"></span><span id='am-232' property="oboInOwl:hasDbXref" content="GO:0005020" datatype="xsd:string"></span><span id='am-233' property="rdfs:label" content="mast/stem cell growth factor receptor" datatype="xsd:string"></span>kit</span> (Amersham). <br />  <br />                               Stable shRNA knockdowns <br />                                             Stable depletion protein levels achieved expression short hairpin RNA <br />                                             (shRNA) pSUPER-RETRO retroviral vector (Oligoengine). sequence WRN- <br />                                             targeting shRNA 5 8242;-GTGTATAGTTACGATGCTA-3 8242; MSH6 5 8242;- <br />                                             GGTGATCCCTCTGAGAACT-3 8242;. control GFP-targeting sequence 5 8242;- <br />                                             GCAAGCTGACCCTGAAGTT-3 8242;. luciferase-targeting sequence 5 8242;- <br />                                             GCGACCAACGCCTTGATTG-3 8242;. Double-stranded oligonucleotides ligated                                             pSUPER-RETRO vector linearized BamHI HindIII. pSUPER- <br />                                             RETRO vectors depletion MLH1 MSH224 details retroviral infections37 <br />                                             described previously. double knockdown experiments, NF cells                                             infected pSUPER-puro vectors, selected puromycin week  <br />                                             infected pSUPER-neo vectors selected 400  956;g/ml geneticin weeks.                                             avoid loss shRNA efficacy long-term cultures, new stocks infected cells used <br />                                             4 weeks. <br />  <br />                               Immunofluorescence <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Cells grown Superfrost Plus slides exposed Cr(VI) 3 hr, returned                                             complete medium. selected times, cells washed twice PBS fixed                                             2% paraformaldehyde PBS 20 min room temperature. Cells                                             permeabilized 20 min 1% Triton X-100, followed incubation 3% fetal <br />                                             bovine serum PBS 1 hr. Primary antibodies WRN (rabbit polyclonal <br />                                             antibodies, Santa Cruz) <span id='am-200' about='obo:IMR_0701328' typeof='owl:Thing'><span id='am-201' property="rdfs:label" content="Nucleolar protein NO38" datatype="xsd:string"></span><span id='am-202' property="oboInOwl:hasExactSynonym" content="nucleophosmin 1" datatype="xsd:string"></span><span id='am-203' property="oboInOwl:hasExactSynonym" content="Numatrin" datatype="xsd:string"></span><span id='am-204' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-205' property="oboInOwl:hasDbXref" content="UniProt:Q61937" datatype="xsd:string"></span><span id='am-206' property="oboInOwl:hasExactSynonym" content="nucleolar protein NO38" datatype="xsd:string"></span><span id='am-207' property="oboInOwl:hasExactSynonym" content="Nucleolar phosphoprotein B23" datatype="xsd:string"></span><span id='am-208' property="oboInOwl:hasExactSynonym" content="Nucleolar protein NO38" datatype="xsd:string"></span><span id='am-209' property="rdfs:label" content="Numatrin" datatype="xsd:string"></span><span id='am-210' property="oboInOwl:hasExactSynonym" content="Npm1" datatype="xsd:string"></span><span id='am-211' property="rdfs:label" content="Nucleophosmin" datatype="xsd:string"></span><span id='am-212' property="oboInOwl:hasExactSynonym" content="NPM" datatype="xsd:string"></span><span id='am-213' property="oboInOwl:hasExactSynonym" content="B23" datatype="xsd:string"></span><span id='am-214' property="rdfs:label" content="Nucleolar phosphoprotein B23" datatype="xsd:string"></span><span id='am-215' property="rdfs:label" content="NO38" datatype="xsd:string"></span><span id='am-216' property="oboInOwl:hasExactSynonym" content="Nucleophosmin" datatype="xsd:string"></span><span id='am-217' property="rdfs:label" content="NPM_MOUSE" datatype="xsd:string"></span><span id='am-218' property="rdfs:label" content="nucleophosmin 1" datatype="xsd:string"></span><span id='am-219' property="rdfs:label" content="NPM" datatype="xsd:string"></span><span id='am-220' property="rdfs:label" content="B23" datatype="xsd:string"></span><span id='am-221' property="rdfs:label" content="Npm1" datatype="xsd:string"></span><span id='am-222' property="rdfs:label" content="nucleolar protein NO38" datatype="xsd:string"></span><span id='am-223' property="oboInOwl:id" content="IMR:0701328" datatype="xsd:string"></span><span id='am-224' property="oboInOwl:hasExactSynonym" content="NO38" datatype="xsd:string"></span>B23</span> (mouse monoclonal <span id='am-476' about='obo:IMR_0002090' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001'><span id='am-477' property="rdfs:label" content="immunoglobulin" datatype="xsd:string"></span><span id='am-478' property="obo:IAO_0000115" content="Antibody molecule (immunoglobulin) consists of four polypeptides chains, two identical light (L) chains and two identical heavy (H) chains.
In mammals, there are five classes of antibodies, IgA, IgD, IgE, IgG, and IgM." datatype="xsd:string"></span><span id='am-479' property="rdfs:label" content="antibody" datatype="xsd:string"></span><span id='am-480' property="oboInOwl:hasExactSynonym" content="antibody" datatype="xsd:string"></span><span id='am-481' property="oboInOwl:id" content="IMR:0002090" datatype="xsd:string"></span><span id='am-482' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-483' property="oboInOwl:hasDbXref" content="GO:0003823" datatype="xsd:string"></span>antibody</span> Chemicon) used                                             1:200 dilution incubated overnight 4 176;C. primary cells Rad51 staining (anti- <br />                                             Rad51 mouse monoclonal antibody Abcam, 1:400 dilution), cells incubated                                             37 176;C 3 hr overnight incubation 4 176;C. DSB repair sites labeled                                             simultaneous incubation primary antibodies  947;-H2AX 1:1000 dilution (Upstate)                                             anti-53BP1 1:500 dilution (Santa Cruz) 2 hr 37 176;C humidified chamber.                                             secondary antibodies, Alexa Fluor 488-conjugated anti-mouse <span id='am-468' about='obo:IMR_0002090' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001'><span id='am-469' property="rdfs:label" content="immunoglobulin" datatype="xsd:string"></span><span id='am-470' property="oboInOwl:hasDbXref" content="GO:0003823" datatype="xsd:string"></span><span id='am-471' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-472' property="oboInOwl:hasExactSynonym" content="antibody" datatype="xsd:string"></span><span id='am-473' property="obo:IAO_0000115" content="Antibody molecule (immunoglobulin) consists of four polypeptides chains, two identical light (L) chains and two identical heavy (H) chains.
In mammals, there are five classes of antibodies, IgA, IgD, IgE, IgG, and IgM." datatype="xsd:string"></span><span id='am-474' property="rdfs:label" content="antibody" datatype="xsd:string"></span><span id='am-475' property="oboInOwl:id" content="IMR:0002090" datatype="xsd:string"></span>immunoglobulin</span> G, Alexa <br />                                             Fluor 594-conjugated anti-mouse <span id='am-484' about='obo:IMR_0002094' typeof='owl:Thing obo:IMR_0002090 obo:IMR_0000949 obo:IMR_0000001'><span id='am-485' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-486' property="rdfs:label" content="IgG" datatype="xsd:string"></span><span id='am-487' property="oboInOwl:hasExactSynonym" content="immunoglobulin G" datatype="xsd:string"></span><span id='am-488' property="oboInOwl:id" content="IMR:0002094" datatype="xsd:string"></span><span id='am-489' property="rdfs:label" content="immunoglobulin G" datatype="xsd:string"></span>immunoglobulin G</span>, Alexa Fluor 488-conjugated anti- <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                           Page 4 <br />  <br />  <br />                                             human immunoglobulin G Alexa Fluor 594-conjugated anti-rabbit immunoglobulin G <br />                                             (Molecular Probes) incubated 1 hr room temperature. Antibodies diluted                                             PBS containing 1% bovine serum albumin 0.5% Tween 20, detection  947;- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             H2AX antibodies diluted 2% albumin-PBS solution. Slides                                             mounted Vectashield hard set mounting medium DAPI (Vector Laboratories). <br />                                             Fluorescence images recorded Zeiss Axiovert 100 confocal microscope                                             analyzed Phoenix software. Experiments repeated 3 8211;6 slides 100 <br />                                             cells analyzed slide. <br />  <br />                               Pulsed-field gel electrophoresis (PFGE) <br />                                             Cells exposed Cr(VI) 3 hr returned complete medium 6 hr 24 hr. <br />                                             PFGE plugs prepared using BioRad Mammalian CHEF Genomic Plug <span id='am-257' about='obo:IMR_0700172' typeof='owl:Thing'><span id='am-258' property="oboInOwl:hasExactSynonym" content="Steel Factor Receptor" datatype="xsd:string"></span><span id='am-259' property="oboInOwl:hasExactSynonym" content="CD117" datatype="xsd:string"></span><span id='am-260' property="oboInOwl:hasExactSynonym" content="EC 2.7.10.1" datatype="xsd:string"></span><span id='am-261' property="rdfs:label" content="Mast/stem cell growth factor receptor" datatype="xsd:string"></span><span id='am-262' property="rdfs:label" content="Tyrosine-protein kinase Kit" datatype="xsd:string"></span><span id='am-263' property="oboInOwl:hasExactSynonym" content="belly-spot" datatype="xsd:string"></span><span id='am-264' property="rdfs:label" content="KIT_MOUSE" datatype="xsd:string"></span><span id='am-265' property="oboInOwl:hasExactSynonym" content="Proto-oncogene c-Kit" datatype="xsd:string"></span><span id='am-266' property="rdfs:label" content="c-KIT" datatype="xsd:string"></span><span id='am-267' property="oboInOwl:hasExactSynonym" content="Tr-kit" datatype="xsd:string"></span><span id='am-268' property="rdfs:label" content="Tr-kit" datatype="xsd:string"></span><span id='am-269' property="oboInOwl:hasExactSynonym" content="Sl" datatype="xsd:string"></span><span id='am-270' property="rdfs:label" content="Gsfsco5" datatype="xsd:string"></span><span id='am-271' property="rdfs:label" content="kit oncogene" datatype="xsd:string"></span><span id='am-272' property="oboInOwl:hasExactSynonym" content="Dominant white spotting" datatype="xsd:string"></span><span id='am-273' property="oboInOwl:hasExactSynonym" content="SCFR" datatype="xsd:string"></span><span id='am-274' property="rdfs:label" content="Proto-oncogene c-Kit" datatype="xsd:string"></span><span id='am-275' property="rdfs:label" content="SOW3" datatype="xsd:string"></span><span id='am-276' property="oboInOwl:hasExactSynonym" content="Gsfsow3" datatype="xsd:string"></span><span id='am-277' property="oboInOwl:hasExactSynonym" content="Tyrosine-protein kinase Kit" datatype="xsd:string"></span><span id='am-278' property="rdfs:label" content="CD117" datatype="xsd:string"></span><span id='am-279' property="oboInOwl:hasExactSynonym" content="c-KIT" datatype="xsd:string"></span><span id='am-280' property="rdfs:label" content="Dominant white spotting" datatype="xsd:string"></span><span id='am-281' property="rdfs:label" content="belly-spot" datatype="xsd:string"></span><span id='am-282' property="oboInOwl:hasExactSynonym" content="Mast/stem cell growth factor receptor" datatype="xsd:string"></span><span id='am-283' property="oboInOwl:hasExactSynonym" content="SCO5" datatype="xsd:string"></span><span id='am-284' property="oboInOwl:hasExactSynonym" content="Gsfsco5" datatype="xsd:string"></span><span id='am-285' property="rdfs:label" content="Steel Factor Receptor" datatype="xsd:string"></span><span id='am-286' property="oboInOwl:hasExactSynonym" content="SOW3" datatype="xsd:string"></span><span id='am-287' property="rdfs:label" content="EC 2.7.10.1" datatype="xsd:string"></span><span id='am-288' property="oboInOwl:hasExactSynonym" content="Gsfsco1" datatype="xsd:string"></span><span id='am-289' property="rdfs:label" content="Sl" datatype="xsd:string"></span><span id='am-290' property="oboInOwl:hasExactSynonym" content="Kit" datatype="xsd:string"></span><span id='am-291' property="rdfs:label" content="SCO1" datatype="xsd:string"></span><span id='am-292' property="oboInOwl:hasExactSynonym" content="kit oncogene" datatype="xsd:string"></span><span id='am-293' property="rdfs:label" content="Kit" datatype="xsd:string"></span><span id='am-294' property="rdfs:label" content="SCFR" datatype="xsd:string"></span><span id='am-295' property="rdfs:label" content="SCO5" datatype="xsd:string"></span><span id='am-296' property="rdfs:label" content="Gsfsco1" datatype="xsd:string"></span><span id='am-297' property="oboInOwl:hasDbXref" content="UniProt:P05532" datatype="xsd:string"></span><span id='am-298' property="rdfs:label" content="Gsfsow3" datatype="xsd:string"></span><span id='am-299' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-300' property="oboInOwl:hasExactSynonym" content="SCO1" datatype="xsd:string"></span><span id='am-301' property="oboInOwl:id" content="IMR:0700172" datatype="xsd:string"></span>Kit</span> 106 cells/ <br />                                             plug incubated proteinase K buffer [100 mM EDTA, 1% N-laurylsarcosyl, 10 mM <br />                                             Tris, pH 8.0, proteinase <span id='am-333' about='obo:IMR_0700139' typeof='owl:Thing'><span id='am-334' property="rdfs:label" content="Keratin-1" datatype="xsd:string"></span><span id='am-335' property="rdfs:label" content="Type-II keratin Kb1" datatype="xsd:string"></span><span id='am-336' property="oboInOwl:hasExactSynonym" content="Type-II keratin Kb1" datatype="xsd:string"></span><span id='am-337' property="oboInOwl:id" content="IMR:0700139" datatype="xsd:string"></span><span id='am-338' property="oboInOwl:hasExactSynonym" content="Keratin-1" datatype="xsd:string"></span><span id='am-339' property="rdfs:label" content="CYTOKERATIN 1" datatype="xsd:string"></span><span id='am-340' property="rdfs:label" content="Cytokeratin-1" datatype="xsd:string"></span><span id='am-341' property="oboInOwl:hasExactSynonym" content="keratin 1" datatype="xsd:string"></span><span id='am-342' property="oboInOwl:hasExactSynonym" content="KRT1A" datatype="xsd:string"></span><span id='am-343' property="rdfs:label" content="Keratin, type II cytoskeletal 1" datatype="xsd:string"></span><span id='am-344' property="oboInOwl:hasExactSynonym" content="CK-1" datatype="xsd:string"></span><span id='am-345' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-346' property="oboInOwl:hasDbXref" content="UniProt:P04264" datatype="xsd:string"></span><span id='am-347' property="oboInOwl:hasExactSynonym" content="Keratin, type II cytoskeletal 1" datatype="xsd:string"></span><span id='am-348' property="rdfs:label" content="CK-1" datatype="xsd:string"></span><span id='am-349' property="rdfs:label" content="67 kDa cytokeratin" datatype="xsd:string"></span><span id='am-350' property="rdfs:label" content="Hair alpha protein" datatype="xsd:string"></span><span id='am-351' property="rdfs:label" content="KRT1" datatype="xsd:string"></span><span id='am-352' property="rdfs:label" content="KRTA" datatype="xsd:string"></span><span id='am-353' property="oboInOwl:hasExactSynonym" content="Hair alpha protein" datatype="xsd:string"></span><span id='am-354' property="rdfs:label" content="K2C1_HUMAN" datatype="xsd:string"></span><span id='am-355' property="oboInOwl:hasExactSynonym" content="KRTA" datatype="xsd:string"></span><span id='am-356' property="oboInOwl:hasExactSynonym" content="KRT1" datatype="xsd:string"></span><span id='am-357' property="oboInOwl:hasExactSynonym" content="67 kDa cytokeratin" datatype="xsd:string"></span><span id='am-358' property="rdfs:label" content="keratin 1" datatype="xsd:string"></span><span id='am-359' property="rdfs:label" content="KRT1A" datatype="xsd:string"></span><span id='am-360' property="oboInOwl:hasExactSynonym" content="K1" datatype="xsd:string"></span><span id='am-361' property="oboInOwl:hasExactSynonym" content="CYTOKERATIN 1" datatype="xsd:string"></span><span id='am-362' property="oboInOwl:hasExactSynonym" content="Cytokeratin-1" datatype="xsd:string"></span><span id='am-363' property="rdfs:label" content="K1" datatype="xsd:string"></span>K 1</span> mg/ml] 20 176;C 24 hr. plugs washed 5 times                                             wash buffer [20 mM Tris, pH 8.0 50 mM EDTA] agitation prior loading. <br />                                             PFGE performed using 1% gel (Pulsefield Certified Megabase Agarose, BioRad)                                             0.5X TBE buffer CHEF Mapper XA Pulsed Field Electrophoresis (BioRad)                                             18 hr 14 176;C following current conditions: 120 176; field angle, 240 s switch time, 4 <br />                                             V/cm. DNA visualized staining ethidium bromide. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Results <br />                               Increased sensitivity WRN-deficient cells Cr(VI) toxicity <br />                                             Expression telomerase known compensate absence WRN human WS <br />                                             cells.38,39 presence active telomerase responsible suppression premature <br />                                             aging phenotype Wrn-knockout <span id='am-537' about='obo:IMR_0703999' typeof='owl:Thing'><span id='am-538' property="rdfs:label" content="MICE" datatype="xsd:string"></span><span id='am-539' property="rdfs:label" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-540' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-541' property="oboInOwl:hasExactSynonym" content="CASP14" datatype="xsd:string"></span><span id='am-542' property="rdfs:label" content="CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE" datatype="xsd:string"></span><span id='am-543' property="oboInOwl:hasExactSynonym" content="MICE" datatype="xsd:string"></span><span id='am-544' property="rdfs:label" content="CASPE_HUMAN" datatype="xsd:string"></span><span id='am-545' property="oboInOwl:hasExactSynonym" content="Caspase-14" datatype="xsd:string"></span><span id='am-546' property="rdfs:label" content="caspase 14, apoptosis-related cysteine peptidase" datatype="xsd:string"></span><span id='am-547' property="oboInOwl:hasExactSynonym" content="CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE" datatype="xsd:string"></span><span id='am-548' property="rdfs:label" content="CASP14" datatype="xsd:string"></span><span id='am-549' property="oboInOwl:hasDbXref" content="UniProt:P31944" datatype="xsd:string"></span><span id='am-550' property="oboInOwl:hasExactSynonym" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-551' property="rdfs:label" content="MGC119078" datatype="xsd:string"></span><span id='am-552' property="rdfs:label" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-553' property="rdfs:label" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-554' property="oboInOwl:id" content="IMR:0703999" datatype="xsd:string"></span><span id='am-555' property="oboInOwl:hasExactSynonym" content="MGC119078" datatype="xsd:string"></span><span id='am-556' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-557' property="rdfs:label" content="Caspase-14" datatype="xsd:string"></span><span id='am-558' property="oboInOwl:hasExactSynonym" content="CASP-14" datatype="xsd:string"></span><span id='am-559' property="oboInOwl:hasExactSynonym" content="caspase 14, apoptosis-related cysteine peptidase" datatype="xsd:string"></span><span id='am-560' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-561' property="rdfs:label" content="CASP-14" datatype="xsd:string"></span><span id='am-562' property="rdfs:label" content="MGC119079" datatype="xsd:string"></span><span id='am-563' property="oboInOwl:hasExactSynonym" content="MGC119079" datatype="xsd:string"></span>mice</span>.40,41 Introduction active hTERT BJ human <br />                                             fibroblasts increased resistance strongly inhibited induction chromosomal <br />                                             instability Cr(VI),42 indicating telomerase-immortalized cells altered <br />                                             processing Cr-induced damage.  chose perform investigation                                             telomerase-negative human cells. potential role WRN helicase cellular responses                                             Cr-DNA damage examined clonogenic survival Cr-treated WRN-expressing <br />                                             NF WRN-null WS fibroblasts (Fig. 1A). WS cells displayed high sensitivity                                             clonogenic lethality Cr(VI) colonies surviving 10  956;M Cr                                             approximately 50% NF cells clonogenically viable dose. NF WS cells <br />                                             isogenic, created stable knockdown WRN protein NF cells expressing                                             targeting shRNA chromosomally integrated pSUPER-RETRO vector (Fig. 1B,                                             panel). selected shRNA decreased WRN levels 10-<span id='am-449' about='obo:IMR_0703347' typeof='owl:Thing'><span id='am-450' property="oboInOwl:hasExactSynonym" content="Ass1" datatype="xsd:string"></span><span id='am-451' property="rdfs:label" content="EC 6.3.4.5" datatype="xsd:string"></span><span id='am-452' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-453' property="rdfs:label" content="Argininosuccinate synthase" datatype="xsd:string"></span><span id='am-454' property="oboInOwl:id" content="IMR:0703347" datatype="xsd:string"></span><span id='am-455' property="oboInOwl:hasExactSynonym" content="Ass-1" datatype="xsd:string"></span><span id='am-456' property="rdfs:label" content="Ass-1" datatype="xsd:string"></span><span id='am-457' property="rdfs:label" content="Ass1" datatype="xsd:string"></span><span id='am-458' property="oboInOwl:hasDbXref" content="UniProt:P16460" datatype="xsd:string"></span><span id='am-459' property="rdfs:label" content="argininosuccinate synthetase 1" datatype="xsd:string"></span><span id='am-460' property="oboInOwl:hasExactSynonym" content="Citrulline--aspartate ligase" datatype="xsd:string"></span><span id='am-461' property="oboInOwl:hasExactSynonym" content="EC 6.3.4.5" datatype="xsd:string"></span><span id='am-462' property="oboInOwl:hasExactSynonym" content="Argininosuccinate synthase" datatype="xsd:string"></span><span id='am-463' property="oboInOwl:hasExactSynonym" content="argininosuccinate synthetase 1" datatype="xsd:string"></span><span id='am-464' property="rdfs:label" content="Citrulline--aspartate ligase" datatype="xsd:string"></span><span id='am-465' property="rdfs:label" content="fold" datatype="xsd:string"></span><span id='am-466' property="oboInOwl:hasExactSynonym" content="fold" datatype="xsd:string"></span><span id='am-467' property="rdfs:label" content="ASSY_MOUSE" datatype="xsd:string"></span>fold</span> compared NF cells <br />                                             expressing nonspecific shRNA (GFP). Using isogenic model WRN deficiency, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             absence WRN caused hypersensitivity Cr(VI) lethality (Fig. 1C). <br />                                             confirm findings, constructed stable WRN knockdown telomerase- <br />                                             negative LNS fibroblasts (Fig. 1B, panel). LNS cells resistant <br />                                             Cr(VI) relative NF cells, WRN knockdown cells resulted essentially                                             degree sensitization Cr(VI) toxicity (Fig. 1D). <br />  <br />                               Altered intranuclear localization WRN Cr(VI) damage <br />                                             WRN typically nucleolus primary transformed human cells.5 <br />                                             Costaining WRN nucleolar marker <span id='am-490' about='obo:IMR_0100236' typeof='owl:Thing obo:IMR_0000272 obo:IMR_0000949 obo:IMR_0010044 obo:IMR_0000001 obo:IMR_0000517 obo:IMR_0000207 obo:IMR_0100209 obo:IMR_0100208'><span id='am-491' property="oboInOwl:id" content="IMR:0100236" datatype="xsd:string"></span><span id='am-492' property="oboInOwl:hasExactSynonym" content="dual specificity protein phosphatase 5" datatype="xsd:string"></span><span id='am-493' property="rdfs:label" content="hVH3" datatype="xsd:string"></span><span id='am-494' property="rdfs:label" content="dual specificity protein phosphatase 5" datatype="xsd:string"></span><span id='am-495' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-496' property="oboInOwl:hasExactSynonym" content="B23" datatype="xsd:string"></span><span id='am-497' property="rdfs:label" content="B23" datatype="xsd:string"></span>B23</span> showed majority NF cells                                             exhibited nucleolar localization WRN (Fig. 2A). response Cr(VI) exposure, WRN <br />                                             relocalized nucleolus nucleoplasm. nucleoplasmic localization                                             observed immediately 3 hr-long exposures 10 8211;20  956;M Cr(VI) retained                                             treated cells 24 hr post-treatment. majority relocalized WRN produced largely <br />                                             uniform diffuse staining pattern. Costaining Cr(VI)-treated cells antibodies WRN <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 5 <br />  <br />  <br />                                             marker DSB,  947; 8211;H2AX,43 showed DSB-positive cells displayed                                             diffuse WRN nuclear distribution  947; 8211;H2AX foci colocalized WRN (Fig. <br />                                             2B,C). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Persistence DSB absence WRN <br />                                             observed colocalization WRN  947; 8211;H2AX foci suggested WRN                                             involved repair Cr(VI)-induced DSB. test possibility, examined effects <br />                                             WRN deficiency persistence DSB Cr(VI) removal. presence DSB <br />                                             detected appearance 53BP1  947; 8211;H2AX foci cells exhibiting focal <br />                                             staining proteins scored DSB-positive (Fig. 3A). 53BP1 recruited <br />                                             following remodeling chromatin regions flanking break44 serves second <br />                                             marker DSB. Levels DSB induced moderate doses Cr(VI) typically approached <br />                                             peak 6 hr post-exposure.23,24 Treatment NF LNS cells moderately <br />                                             toxic Cr(VI) doses (~60% clonogenic survival) resulted strong production DSB <br />                                             foci 6 hr post-Cr WRN depletion significant effect initial induction                                             DSB (Fig. 3B,C).  24 hr post-exposure, approximately twice                                             DSB foci-positive cells WRN knockdown compared shGFP controls. Cr(VI) <br />                                             requires reductive activation inside cells order cause DNA damage.45 Human cells                                             culture contain low levels ascorbate,25,35 rapid cellular reducer                                             Cr(VI).46,47 Restoration physiological levels ascorbate primary human cells strongly <br />                                             potentiated formation DSB Cr(VI).24 HPLC analyses detected approximately <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             25  956;M ascorbate NF cells, lower physiological levels vitamin <br />                                             tissues.47  preloaded NF cells ascorbate 0.25 mM                                             examined DSB accumulation 24 hr post-Cr (Fig. 3D,E). primary cells,24 increasing <br />                                             cellular ascorbate levels enhanced DSB-producing activity Cr(VI), WRN depletion <br />                                             resulted presence persistent DSB exposure low 2  956;M Cr(VI), <br />                                             current <span id='am-1' about='obo:IMR_0001386' typeof='owl:Thing'><span id='am-2' property="oboInOwl:hasExactSynonym" content="cAMP-dependent protein kinase R2" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="cAMP-dependent protein kinase type II regulatory subunit" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasExactSynonym" content="Cos-1" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="UniProt:P81900" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="RII[[DR]]" datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="BcDNA:GM01761" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="KAPR2_DROME" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="CG15862" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasExactSynonym" content="Epaulette" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasExactSynonym" content="Cos1" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasExactSynonym" content="Costal-1" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0001386" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Costal-1" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasExactSynonym" content="PKA-RII" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="PKa-R2" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="PKa-R2" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="costal-1" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasExactSynonym" content="Epa" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="PKA-RII" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="Cos" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Costal" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="Epaulette" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="pka-RII" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="cos1" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasExactSynonym" content="Pka-R2" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="Pka-R2" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="CG15862" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasExactSynonym" content="RII" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="cAMP-dependent protein kinase type II regulatory subunit" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="Cos-1" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="cAMP-dependent protein kinase type II" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="RII" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasExactSynonym" content="pka-RII" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="Pka-RII" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasExactSynonym" content="pkA" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="cAMP-dependent protein kinase R2" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Cos1" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="Epa" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasExactSynonym" content="cAMP-dependent protein kinase type II" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="costal-1" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasExactSynonym" content="RII[[DR]]" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="PKA RII" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasExactSynonym" content="Cos" datatype="xsd:string"></span><span id='am-46' property="rdfs:label" content="cos1" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="pkA" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasExactSynonym" content="BcDNA:GM01761" datatype="xsd:string"></span><span id='am-49' property="rdfs:label" content="PKA" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasExactSynonym" content="PKA" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasExactSynonym" content="PKA RII" datatype="xsd:string"></span><span id='am-52' property="rdfs:label" content="Pka-RII" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="Costal" datatype="xsd:string"></span>EPA</span> standard chromium drinking water.47 Analysis                                             chromosomal DNA PFGE confirmed importance WRN repair Cr- <br />                                             induced DSB evidenced 2.7-times (p&lt;0.01) higher levels remaining DNA breaks                                             WRN-depleted LNS cells 24 hr Cr(VI) exposure (Fig. 3F). Control LNS cells                                             normal WRN levels capable repairing majority DSB generated                                             50  956;M Cr(VI) WRN-depleted cells unable significant repair                                             fewer DSB induced 30  956;M Cr(VI) (Fig. 3G). <br />  <br />                               Attenuated formation RAD51 foci WRN-deficient cells <br />                                             majority Cr-induced DSB present G2 cells.23,24 DSB repair G2 cells <br />                                             occurs primarily homologous recombination,48,49 examined effect WRN                                             repair process. activity recombination repair assessed scoring foci NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             RAD51, essential recombination repair proteinsand specific marker                                             recombination repair sites.50 Treatment NF cells moderate 10  956;M highly <br />                                             toxic 20  956;M doses Cr(VI) did increase production RAD51 foci                                             background levels 6 hr post-exposure (Fig. 4A,B). 24 hr post-Cr, NF cells                                             nonspecific GFP-shRNA displayed significant induction RAD51 foci Cr(VI) <br />                                             doses WRN-depleted cells showed change relative untreated controls.  <br />                                             activation recombination repair NF cells significantly lagged induction DSB                                             presence WRN (Fig. 3B,C) absent cells WRN knockdown.                                             confirm findings, investigated formation RAD51 foci LNS cells (Fig. 4C). <br />                                             Control LNS cells showed strong induction RAD51 foci 6 hr post-Cr                                             WRN depletion completely abrogated recombination foci time. 24 hr post-Cr, <br />                                             WRN-depleted LNS cells displayed significant increase number RAD51 foci, <br />                                             modestly lower control cells.  cell lines showed strong <br />                                             positive effect WRN formation RAD51 foci. rapid activation  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                           Page 6 <br />  <br />  <br />                                             recombination repair LNS cells partially responsible higher <br />                                             resistance Cr(VI) lethality (Fig. 1D). analyzed RAD51 foci WRN-null WS <br />                                             cells treated 10 20  956;M Cr(VI), doses clearly genotoxic cells (Fig. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             1A). Cr(VI) dose caused marginal increase induction RAD51 foci                                             24 hr post-exposure (Fig. 4D), confirming importance WRN protein                                             initiation recombination repair Cr-DNA damage. large fraction Cr-induced <br />                                             RAD51 focus-positive NF LNS cells showed partial colocalization (ranging                                             20 80%) RAD51 foci WRN (Fig. 4E,F). <br />  <br />                               Mismatch repair (MMR)-mediated DNA lesions WRN <br />                                             main cause DSB human cells treated low moderately toxic doses Cr(VI) <br />                                             abnormal processing Cr-DNA crosslinks MMR.23 8211;25 observed                                             ascorbate, enhances DSB production aberrant MMR activity,24 increased                                             levels DNA breaks WRN-depleted cells Cr(VI) concentrations                                             nongenotoxic (Fig. 3D,E).  tested WRN responding secondary <br />                                             DNA lesions generated MMR. examined dynamics WRN localization                                             Cr(VI)-treated human HCT116 cells lacking expressing MLH1,                                             essential MMR proteins.33,34 majority control cells lines showed costaining <br />                                             WRN nucleolar marker <span id='am-668' about='obo:IMR_0701326' typeof='owl:Thing'><span id='am-669' property="oboInOwl:hasExactSynonym" content="NPM" datatype="xsd:string"></span><span id='am-670' property="oboInOwl:hasExactSynonym" content="Numatrin" datatype="xsd:string"></span><span id='am-671' property="rdfs:label" content="B23" datatype="xsd:string"></span><span id='am-672' property="rdfs:label" content="NPM_HUMAN" datatype="xsd:string"></span><span id='am-673' property="oboInOwl:id" content="IMR:0701326" datatype="xsd:string"></span><span id='am-674' property="rdfs:label" content="nucleophosmin (nucleolar phosphoprotein B23, numatrin)" datatype="xsd:string"></span><span id='am-675' property="rdfs:label" content="Nucleolar phosphoprotein B23" datatype="xsd:string"></span><span id='am-676' property="oboInOwl:hasDbXref" content="UniProt:P06748" datatype="xsd:string"></span><span id='am-677' property="oboInOwl:hasExactSynonym" content="nucleophosmin (nucleolar phosphoprotein B23, numatrin)" datatype="xsd:string"></span><span id='am-678' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-679' property="rdfs:label" content="Nucleophosmin" datatype="xsd:string"></span><span id='am-680' property="oboInOwl:hasExactSynonym" content="NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1" datatype="xsd:string"></span><span id='am-681' property="rdfs:label" content="Nucleolar protein NO38" datatype="xsd:string"></span><span id='am-682' property="oboInOwl:hasExactSynonym" content="MGC104254" datatype="xsd:string"></span><span id='am-683' property="oboInOwl:hasExactSynonym" content="Nucleolar protein NO38" datatype="xsd:string"></span><span id='am-684' property="rdfs:label" content="Numatrin" datatype="xsd:string"></span><span id='am-685' property="rdfs:label" content="NPM1" datatype="xsd:string"></span><span id='am-686' property="rdfs:label" content="NPM" datatype="xsd:string"></span><span id='am-687' property="oboInOwl:hasExactSynonym" content="B23" datatype="xsd:string"></span><span id='am-688' property="oboInOwl:hasExactSynonym" content="Nucleophosmin" datatype="xsd:string"></span><span id='am-689' property="oboInOwl:hasExactSynonym" content="Nucleolar phosphoprotein B23" datatype="xsd:string"></span><span id='am-690' property="oboInOwl:hasExactSynonym" content="NPM1" datatype="xsd:string"></span><span id='am-691' property="rdfs:label" content="NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1" datatype="xsd:string"></span><span id='am-692' property="rdfs:label" content="MGC104254" datatype="xsd:string"></span>B23</span>, demonstrating MLH1 effect                                             retention WRN nucleoli unstressed cells (Fig. 5A). Immediately Cr(VI) <br />                                             exposure, WRN dispersed nucleolus nucleoplasm majority cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             irrespective MLH1 status. Similarly NF cells (Fig. 2), MLH1+ HCT116 cells                                             retained nucleoplasmic WRN 24 hr post-Cr. contrast, MLH1 8722;/ 8722; HCT116 cells restored <br />                                             normal nucleolar localization WRN 3 8211;6 hr post-exposure. investigate                                             MMR-dependence WRN dynamics, created stable knockdowns MLH1 MSH2 <br />                                             MMR proteins primary human IMR90 fibroblasts (Fig. 5B). WRN <br />                                             relocalized IMR90 constructs immediately Cr(VI) exposure control <br />                                             Luc-shRNA cells retained WRN nucleoplasm, cells MLH1 MSH2 <br />                                             knockdowns restored nucleolar WRN staining 3 hr post-Cr (Fig. 5C).                                              initial relocalization WRN occurred directly response Cr(VI)-induced stress                                             long-term retention nucleoplasm required presence MMR proteins.                                             nucleoplasmic retention WRN binding MMR proteins,  <br />                                             immunoprecipitation experiments detectable association WRN MSH6                                             MSH2 control Cr(VI)-treated NF cells (Fig. 5D). MSH6 immunoprecipitates contained <br />                                             large amounts binding partner MSH2,33,34 validating effectiveness                                             employed procedure. Sensitization WRN-depleted cells Cr(VI) toxicity did appear <br />                                             result alterations MMR expression major MMR <br />                                             proteins MSH6, MSH2 MLH1 did vary GFP-shRNA WRN-shRNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             cells (Fig. 5E). Cr(VI) exposure significant effect protein levels WRN <br />                                             itself (Fig. 5E). <br />  <br />                                             observed MMR-dependent dynamics WRN absence direct interactions                                             MMR proteins suggested WRN responding MMR-induced DSB. test                                             possibility, constructed NF cells double knockdowns MSH6 WRN (Fig. 6A). <br />                                             depending Cr(VI) dose, knockdown MSH6 WRN-depleted cells <br />                                             completely abrogated significantly suppressed levels persistent DSB foci <br />                                             (Fig. 6B). presence ascorbate strongly potentiated formation DSB Cr(VI) <br />                                             (Fig. 3E) low doses essentially ascorbate-promoted DSB MMR-generated.24 <br />                                             depletion MSH6 completely eliminated presence persistent DSB                                             Cr-treated/ascorbate-preloaded cells WRN knockdown (Fig. 6C). effect quite <br />                                             striking, cells normal WRN levels (GFP/GFP controls) unable fully <br />                                             repair DSB. DSB induction, formation RAD51 foci Cr(VI) enhanced <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 7 <br />  <br />  <br />                                             preloading control cells ascorbate MSH6 depletion abrogated appearance <br />                                             recombination-active cells (Fig. 6D,E). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Discussion <br />                                             work, WRN actively engaged cellular responses Cr(VI). <br />                                             Immediately short treatments carcinogen, WRN relocalized                                             nucleolus nucleoplasm remained 24 hr post-exposure. loss                                             WRN resulted increased clonogenic toxicity Cr(VI), demonstrating importance                                             RecQ-type helicase cell survival. Cellular reduction Cr(VI) generates transient <br />                                             oxidative stress formation redox-active CrV/IV intermediates51,52 yields <br />                                             stable Cr-DNA adducts.45 prolonged nucleoplasmic retention WRN Cr-treated <br />                                             cells, initial relocalization, dependent presence intact MMR.  <br />                                             early WRN movement likely caused cellular stress Cr(VI) metabolism <br />                                             subsequent nucleoplasmic presence reflected events involving MMR. <br />                                             Processing Cr-DNA adducts human MMR generates DSB secondary, toxic <br />                                             DNA lesions.23 8211;25 WRN played major role repair MMR-induced DSB <br />                                             Cr(VI)-treated human fibroblasts significant effects initial production                                             DNA breaks. presence unrepaired DSB likely responsible decreased <br />                                             survival WRN-depleted cells clonogenic assay. Poor repair DSB WRN- <br />                                             lacking cells associated deficiency activation early steps homologous <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             recombination, revealed absence severely delayed formation RAD51 foci <br />                                             Cr-DNA damage. Functional recombination repair known play important role <br />                                             cellular resistance Cr(VI) toxicity.53,54 <br />  <br />                                             Induction DSB MMR typically begins 1 8211;3 hr post-Cr exposure occurs                                             G2 cells following replication Cr-adducted DNA.23,24 late steps MMR- <br />                                             dependent processing Cr-DNA damage prior DNA breakage dependent                                             activity MSH3-MSH2 heterodimer (MutS 946; complex).25 MutS 946; dimer exhibits high <br />                                             specificity DNA loops various sizes,33,34 suggesting MMR-induced DSB                                             associated presence loops hairpins. presence loops hairpins <br />                                             interfere activity DNA-processing enzymes, DNA ends adjacent <br />                                             loops high affinity substrates WRN.2 Additionally, strong requirement WRN                                             initiation RAD51-dependent recombination Cr-treated cells                                             reflected limited availability EXO1 operates parallel pathway leading                                             activation recombination repair DSB.20 8211;22 role RecQ helicases DSB <br />                                             processing evident cells deficient EXO1/Exo1. EXO1 <br />                                             essential component human MMR,33,34 massive formation ternary Cr-DNA <br />                                             adducts recruiting MMR complexes stimulating activity expected sequester NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             major fraction low abundance exonuclease.22 <br />  <br />                                             MSH2-MSH3 MSH2-MSH6 mismatch-sensing complexes capable                                             stimulating DNA duplex unwinding WRN vitro.55 biological relevance                                             findings supported physical interactions WRN MSH2 yeast <br />                                             hybrid studies. High duplex unwinding activity promote DSB repair, helicase <br />                                             activity essential 5 8242; 8594;3 8242; exonuclease degradation DSB ends RecQ/Sgs1- <br />                                             dependent recombination process.20 8211;22 MMR proteins present sites Cr- <br />                                             induced DSB,25 recruit WRN stimulate strand unwinding activity                                             contribute prominent role DSB ends processing necessary RAR51 <br />                                             loading.  far unable detect interactions WRN MSH2                                             MSH6 IP control Cr(VI)-treated cells. possible association                                             WRN MMR proteins predominantly occurs chromatin-bound DSB repair complexes <br />                                             remained insoluble protein extraction procedures IP procedure <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                                           Page 8 <br />  <br />  <br />                                              employed stringent lysis/washing conditions. Alternatively, WRN recruited                                              sites Cr-induced DSB components MMR, upstream-acting MLH1- <br />                                              PMS2 heterodimer.55 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Implications Cr(VI) genotoxicity <br />                                              Long DSB persistence defective formation RAD51 recombination foci absence <br />                                              WRN indicate repair MMR-induced DSB Cr(VI)-treated fibroblasts                                              dependent helicase.  unlike types DSB processed                                              recombination repair RecQ-dependent independent (EXO1) pathways,20 8211;22                                              reliance WRN-dependent process repair Cr/MMR-induced breaks result                                              persistent DSB. Cr(VI)-treated cells did display relatively slow DSB repair                                              phenomenon particularly noticeable primary human cells showed steady <br />                                              accumulation DSB hours exposure subtoxic environmental doses <br />                                              Cr(VI).24,25 High promoter-repressive activity Rb complexes primary cells results                                              low levels WRN expression,56 limit repair rates Cr-induced DSB                                              tissues. Persistent DSB cause variety gross genetic rearrangements, including <br />                                              chromosomal deletions translocations,57,58 likely contributing high <br />                                              carcinogenicity moderate chromate exposures modern workplace <br />                                              environment.47,59 Consequently, individuals low WRN levels greater risk <br />                                              Cr(VI)-associated genotoxicity carcinogenesis. Cr(VI)-induced DSB                                              predominantly G2 cells repair requires WRN, restrict WRN <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              availability biological functions rebuilding telomere structures                                              occurs G2 phase.60  potential consequences competition WRN <br />                                              telomeric functions DSB repair slower rates processes  <br />                                              possibly, accelerated attrition telomeres cells individuals chronically exposed                                              Cr(VI). <br />  <br />  <br />                               Abbreviations <br />                                             DSB             double-strand break <br />                                             MMR             mismatch repair <br />                                             PBS             phosphate-buffered saline <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             shRNA           short hairpin RNA <br />                                             PFGE            pulsed-field gel electrophoresis <br />  <br />   <br />                                             Figure 1. Loss WRN decreases survival cells treated Cr(VI) <br />                                             Cell survival determined clonogenic assay. Results means 177;<span id='am-234' about='obo:IMR_0703821' typeof='owl:Thing'><span id='am-235' property="rdfs:label" content="Ran GTPase activating protein 1" datatype="xsd:string"></span><span id='am-236' property="oboInOwl:hasExactSynonym" content="Fug1" datatype="xsd:string"></span><span id='am-237' property="rdfs:label" content="MGC20266" datatype="xsd:string"></span><span id='am-238' property="rdfs:label" content="SD" datatype="xsd:string"></span><span id='am-239' property="rdfs:label" content="GTPase-ACTIVATING PROTEIN, RAN, 1" datatype="xsd:string"></span><span id='am-240' property="oboInOwl:hasExactSynonym" content="RANGAP1" datatype="xsd:string"></span><span id='am-241' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-242' property="rdfs:label" content="RAGP1_HUMAN" datatype="xsd:string"></span><span id='am-243' property="oboInOwl:hasExactSynonym" content="GTPase-ACTIVATING PROTEIN, RAN, 1" datatype="xsd:string"></span><span id='am-244' property="oboInOwl:hasExactSynonym" content="MGC20266" datatype="xsd:string"></span><span id='am-245' property="rdfs:label" content="RANGAP1" datatype="xsd:string"></span><span id='am-246' property="oboInOwl:hasExactSynonym" content="KIAA1835" datatype="xsd:string"></span><span id='am-247' property="oboInOwl:hasDbXref" content="UniProt:P46060" datatype="xsd:string"></span><span id='am-248' property="oboInOwl:id" content="IMR:0703821" datatype="xsd:string"></span><span id='am-249' property="oboInOwl:hasExactSynonym" content="Ran GTPase-activating protein 1" datatype="xsd:string"></span><span id='am-250' property="oboInOwl:hasExactSynonym" content="Ran GTPase activating protein 1" datatype="xsd:string"></span><span id='am-251' property="rdfs:label" content="RanGAP1" datatype="xsd:string"></span><span id='am-252' property="oboInOwl:hasExactSynonym" content="RanGAP1" datatype="xsd:string"></span><span id='am-253' property="rdfs:label" content="KIAA1835" datatype="xsd:string"></span><span id='am-254' property="oboInOwl:hasExactSynonym" content="SD" datatype="xsd:string"></span><span id='am-255' property="rdfs:label" content="Fug1" datatype="xsd:string"></span><span id='am-256' property="rdfs:label" content="Ran GTPase-activating protein 1" datatype="xsd:string"></span>SD</span> 2 8211;3 <br />                                             independent experiments, triplicate dishes dose. seen, error bars <br />                                             smaller symbol. Statistics (Student 8217;s t-test): *- p&lt;0.05, **- p&lt;0.01 relative                                             WRN-deficient cells.   Clonogenic viability WS NF fibroblasts treated                                             Cr(VI). (B) WRN levels NF  panel) LNS (lower panel) cells expressing targeting <br />                                             nonspecific (GFP) shRNA. (C) Cr(VI) toxicity NF cells expressing WRN-targeting NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             nonspecific (GFP) shRNA. (D) Survival LNS cells expressing WRN GFP-targeting <br />                                             shRNA. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                       Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 2. Cr(VI) causes dispersion WRN nucleolus <br />                                               Confocal images control 20  956;M Cr(VI)-treated NF cells immunostained                                             WRN nucleolar marker B23. (B) representative confocal image Cr-treated cells <br />                                             displaying colocalization WRN  947;-H2AX foci. (C) Presence  947;-H2AX foci NF cells <br />                                             different patterns WRN staining. Cells treated 20 956;M Cr(VI) fixed                                             immunostaining indicated times. Data means 177;SD slides &gt;100 cells <br />                                             scored slide. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                        Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 3. Persistence Cr-induced DSB WRN-depleted cells <br />                                               Confocal images GFP WRN-shRNA expressing NF cells stained DAPI                                             antibodies 53BP1  947;-H2AX. Shown representative images untreated 10 <br />                                              956;M Cr-treated cells 6 hr post-exposure. (B) Frequency DSB-positive NF cells 6                                             24 hr exposure 10  956;M Cr(VI). Cells  8805;5 foci 53BP1  947;-H2AX NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             counted DSB-positive. WRN -cells expressing WRN-targeting shRNA, GFP - cells <br />                                             expressing nonspecific shRNA. Data means  177;SD 5 slides &gt;100 cells analyzed <br />                                             slide. Statistics: *- p&lt;0.05, **- p&lt;0.01 relative shGFP cells. (C) Frequency DSB- <br />                                             positive LNS cells following exposure 30  956;M Cr(VI). Definitions cells panel <br />                                             B. Results means 177;SD 3 slides &gt;100 cells counted slide. (D) DSB levels                                             normally cultured NF cells 24 hr post-exposure low Cr(VI) doses. Data means  177;SD <br />                                             4 slides &gt;100 cells analyzed slide. (E) Elevated DSB levels NF cells <br />                                             preloaded 0.25 mM ascorbic acid prior Cr(VI) exposure. DSB foci counted                                             24 hr post-Cr. Data means 177;SD 4 slides &gt;100 cells counted slide. (F) <br />                                             Determination DSB repair PFGE LNS cells treated 30  956;M Cr(VI) (means <br />                                              177;SD). (G) PFGE chromosomal DNA shGFP- shWRN-LNS cells treated                                             50 30  956;M Cr(VI), respectively. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                            Page 15 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 4. WRN depletion inhibits formation RAD51 foci Cr-treated cells <br />                                               Representative confocal images NF LNS cells stained DAPI anti- <br />                                             RAD51 antibody. Cells treated 10  956;M (NF cells) 30  956;M Cr(VI) (LNS cells)                                             3 hr fixed 6 24 hr later. (B) Induction RAD51 foci Cr(VI) NF cells. Cells NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             3 foci scored focus-positive. Data means 177;SD 4 slides &gt;100 <br />                                             cells scored slide. (C) Formation RAD51 foci LNS cells treated 30  956;M <br />                                             Cr(VI). Data means 177;SD 4 slides &gt;100 cells counted slide. Statistics                                             panels B C: *-p&lt;0.05, **- p&lt;0.01 relative shGFP cells. (D) Number RAD51 foci- <br />                                             positive WS cells 24 hr post-Cr. Data means 177;SD 3 slides 100 cells <br />                                             scored slide. (E) Colocalization WRN RAD51 foci LNS cells 6 24 hr <br />                                             treatment 30  956;M Cr(VI). (F) WRN RAD51 colocalization NF cells 24 hr <br />                                             following exposure 10  956;M Cr(VI). panels E F, nuclei containing clear <br />                                             RAD51 focus colocalizing WRN scored positive. Typical colocalization                                             positive cells 20 8211;80% RAD51 foci.  8220; 8722; 8221; Frequency RAD51-positive cells <br />                                             WRN colocalization,  8220;+ 8221;  8211;frequency cells RAD51 WRN colocalization. <br />                                             Results means 177;SD 3 slides &gt;30 RAD51 foci-containing cells scored                                             colocalization. Statistics panels E F: *-p&lt;0.05, **- p&lt;0.01 relative untreated cells. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 16 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 5. Nucleoplasmic retention WRN Cr(VI)-treated cells requires intact MMR <br />                                               Frequency MLH1 8722;/ 8722; MLH1+ HCT116 cells nucleoplasmic WRN following <br />                                             treatment 20  956;M Cr(VI) (means 177;SD 3 slides &gt;100 cells analyzed/slide). <br />                                             Statistics: *- p&lt;0.05, **- p&lt;0.01 relative MLH1 8722;/ 8722; cells. (B) Western blot protein <br />                                             extracts IMR90 cells expressing nonspecific (Luc), MSH2 MLH1-targeting shRNA. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             (C) Quantitation nuclear WRN dispersion IMR90 cells treated 10  956;M Cr(VI) <br />                                             (means 177;SD 3 slides &gt;100 cells analyzed/slide). Statistics: *- p&lt;0.05, **- p&lt;0.01 <br />                                             relative MLH1- MSH2-shRNA. (D) Coimmunoprecipitation WRN MSH6                                             MSH2 control 20  956;M Cr-treated NF cells. (E) Expression MMR proteins GFP- <br />                                             shRNA WRN-shRNA NF cells exposure 20 956;M Cr(VI). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                        Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 6. Rescue WRN hypersensitivity MSH6 depletion <br />                                               Western blot MSH6 WRN NF cells double shRNA infections. WRN- <br />                                             shRNA expressed pSUPER-puro vector, MSH6  8211; pSUPER-neo                                             nonspecific GFP-shRNA expressed pSUPER-puro pSUPER-neo <br />                                             depending resistance marker targeting vector. (B) DSB foci (53BP1 +  947;-H2AX) <br />                                             WRN-depleted NF cells MSH6 knockdown ( 9679; - WRN-GFP shRNAs,  9633; <br />                                             - GFP-GFP shRNAs,  9671;- GFP-MSH6 shRNAs,  9650;-WRN-MSH6 shRNAs). Cells                                             treated Cr(VI) 3 hr fixed immunofluorescence 24 hr later. Data means <br />                                              177;SD 3 slides &gt;100 cells counted slide (*- p&lt;0.05 GFP/GFP WRN/ <br />                                             MSH6 relative WRN/GFP cells). (C) Frequency DSB-positive double knockdown NF <br />                                             cells preloaded 0.25 mM ascorbate prior 5  956;M Cr(VI) exposure. Cells fixed NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             DSB foci scoring (53BP1 +  947;-H2AX foci) 24 hr post-Cr. Shown means 177;SD 3 <br />                                             slides &gt;100 cells counted slide (*- p&lt;0.05, **-p&lt;0.01 relative untreated cells). <br />                                             (D) Frequency RAD51 foci-positive NF cells expressing nonspecific (GFP) MSH6- <br />                                             targeting shRNA following exposure Cr(VI) normal culture conditions. RAD51 <br />                                             foci scored 24 hr post-treatment. Data means 177;SD 3 slides &gt;100 cells <br />                                             counted slide. (E) panel D cells preloaded 0.25 mM ascorbate <br />                                             prior treatments Cr(VI). Data means 177;SD 3 slides. Statistics panels D                                             E: *- p&lt;0.05, **- p&lt;0.01 relative shGFP cells. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />   <br /> </body></html>